首页 > 化工企业 > MedChemexpress > 帕布昔利布盐酸盐
MedChemexpress

货号: HY-50767A

帕布昔利布盐酸盐

  • 827022-32-2
  • C24H30ClN7O2
  • 98%
  • 7日

销 售 价 ¥700.00 /mg

选择规格
  • 5mg
全部
最小起订
1mg
支付方式
e商贷 摩易付

摩贝商家

商家名称
MedChemexpress
所在地区
美国 新泽西 纽瓦克
公司电话
609-2286898
联系手机
18019480960
认证属性
试剂

店内搜索

热销产品

perampanel

(380917-97-5)

¥1540

盐酸纳曲酮

(16676-29-2)

¥400

唑吡坦

(82626-48-0)

¥1023

地西泮

(439-14-5)

¥930

普瑞巴林

(148553-50-8)

¥550

  • 商品详情
  • 商品评价
  • MSDS
信息更新时间:2018.06.10
  • 帕布昔利布盐酸盐
  • 98%
  • 5mg
  • 1 mg
  • 7日
  • HY-50767A
化合物信息 [查看化合物百科]
化合物英文学名 Palbociclib hydrochloride 化合物中文学名 帕布昔利布盐酸盐
CAS号 827022-32-2 分子式 C24H30ClN7O2
分子量 483.994 精确质量 483.215
LogP 4.2346 PSA 105.04
沸点 727ºC at 760 mmHg 闪点 393.5ºC
详细描述
产品描述:Palbociclib hydrochloride is a highly specific inhibitor of Cdk4 (IC50=11 nM) and Cdk6 (IC50=16 nM), having no activity against a panel of 36 additional protein kinases. IC50 & Target: IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1]In Vitro: The IC50 of Palbociclib (PD 0332991) for reduction of retinoblastoma (Rb) phosphorylation at Ser780 in MDA-MB-435 breast carcinoma cells is 66 nM. Palbociclib is equally effective at reducing Rb phosphorylation at Ser795 in this tumor with an IC50 of 63 nM, and similar effects on both Ser780 and Ser795 phosphorylation are obtained in the Colo-205 colon carcinoma[1]. The MP-MRT-AN (AN), KP-MRT-RY (RY), G401, and KP-MRT-NS (NS) cell lines are effectively inhibited by Palbociclib (PD) in a concentration-dependent manner in a WST-8 assay. The IC50s are 0.01 μM, 0.01 μM, 0.06 μM, and 0.6 μM, respectively. In contrast, the KP-MRT-YM (YM) cell line is resistant to Palbociclib (IC50>10 μM). The flow cytometry results show that Palbociclib at concentrations between 0 to 1.0 μM induces G1 arrest in the AN, RY, G401 and NS cell lines in a concentration-dependent manner, but has no effect on YM cells. The BrdU incorporation results are consistent with the WST-8 and flow cytometry results: PD reduces BrdU incorporation (indicating G1 arrest) in the AN, RY, G401 and NS cell lines, but not in the YM cell line. Palbociclib, even at a concentration of 0.05 μM, significantly reduces BrdU incorporation in the AN, RY, and G401 cell lines (p<0.05)[2].In Vivo: Palbociclib (PD 0332991) exhibits significant antitumor efficacy against multiple human tumor xenograft models. In mice bearing Colo-205 colon carcinoma xenografts (p16 deleted), daily p.o. dosing for 14 days with Palbociclib (150 or 75 mg/kg) produces rapid tumor regressions and a corresponding tumor growth delay of -50 days with >1 log of tumor cell kill at the highest dose tested. At 37.5 mg/kg, the tumor slowly regressed during treatment. Even at doses as low as 12.5 mg/kg, a 13-day growth delay is obtained indicating a 90% inhibition of tumor growth rate. Likewise, robust antitumor activity is seen in the MDA-MB-435 breast carcinoma (p16 deleted) where complete tumor stasis is apparent at 150 mg/kg and some cell kill is evident at the highest dose[1].
产品链接:http://www.medchemexpress.com/Cot-inhibitor-2.html
产品链接:http://www.medchemexpress.cn/palbociclib-hydrochloride.html

该公司尚未提供产品的MSDS报告,下部信息为摩贝百科数据库为您提供的MSDS信息,供您参考。

提醒该企业完善MSDS信息
MSDS

采购信息

帕布昔利布盐酸盐

827022-32-2

*
*
*
*
*
 
 
 

购物车 0

不要让您的购物车空着哦,买试剂买原料
如果您已添加过宝贝,那就赶紧登录查看吧

投诉建议

  • 咨询类别
  • 问题描述
  • 联系人电话
  • 联系人

化工圈APP

二维码

微信公众号

二维码